Results 21 to 30 of about 27,152 (204)

Severe myopathy in a patient with chronic neurological disease – diagnostic challenges [PDF]

Romanian Journal of Rheumatology, 2023
Polymyositis is a rare disease that belongs to the idiopathic inflammatory myopathies (IIMs) group, characterized by chronic muscle inflammation, and in rare cases a life-threatening condition due to extra-muscular involvement.
Cristian-Mihai Ilie, Suzana Popescu, Sinziana Daia-Iliescu, Ioana Saulescu, Denisa Predeteanu, Violeta-Claudia Bojinca, Andra Balanescu, Daniela Opris-Belinski   +7 more
doaj   +1 more source

Polymyositis-Like Myopathy With Anti-PL-12 Antibody Positivity and Coexisting Antiphospholipid Syndrome: Diagnostic and Management Challenges in the Absence of Systemic Features. [PDF]

Cureus
Parga AD, Raheem I.
europepmc   +2 more sources

A Curious Case of Proximal Muscle Weakness with Eosinophilic Polymyositis

Case Reports in Rheumatology, 2016
Eosinophilic polymyositis (EPM) is part of a rare disorder, eosinophilic myopathies (EM), which is a form of polymyositis characterized by the presence of eosinophils in muscle biopsy sections and occasionally blood eosinophilia.
Ciel Harris, Robert Ali, Julio Perez-Downes, Firas Baidoun, Marianne DeLima, Jaimin Shah, Win Aung, Raafat F. Makary   +7 more
doaj   +1 more source

Bilateral leg pain and unilateral calf atrophy caused by polymyositis accompanying lumbar spinal stenosis and disc herniation: a case report

Journal of International Medical Research, 2022
Polymyositis is a subgroup of idiopathic inflammatory myopathies characterized by symmetric proximal limb weakness and chronic skeletal muscle inflammation.
In-Hwa Baek, Hyung-Youl Park, Ho-Young Jung, Jun-Seok Lee   +3 more
doaj   +1 more source

Case report: Systemic muscle involvement as the primary clinical manifestation of chronic active Epstein–Barr virus infection: A case-based review

Frontiers in Immunology, 2022
Chronic active Epstein–Barr virus infection (CAEBV) is common in Asian countries and characterized by recurrent or persistent infectious mononucleosis-like symptoms.
Shanfen Shi, Liangda Li, Cuiping Pan, Yandi Yang, Gun Chen, Yongping He   +5 more
doaj   +1 more source

Profiling of Myositis Specific Antibodies and Composite Scores as an Aid in the Differential Diagnosis of Autoimmune Myopathies

Diagnostics, 2021
(1) Background: Myositis specific antibodies (MSA) represent important diagnostic and stratification tools in idiopathic inflammatory myositis (IIM) patients.
Michael Mahler, Kishore Malyavantham, Andrea Seaman, Chelsea Bentow, Ariadna Anunciacion-Llunell, María Teresa Sanz-Martínez, Laura Viñas-Gimenez, Albert Selva-O’Callaghan   +7 more
doaj   +1 more source

Cardiac involvement in polymyositis and dermatomyositis: diagnostic approaches.

Rheumatology, 2023
Polymyositis (PM) and dermatomyositis (DM) are rare idiopathic inflammatory myopathies (IIM). Myocardial involvement in patients with IIM is an unfavorable prognostic factor and one of the most common cause of mortality in this group of patients.
Agnieszka Trybuch, Beata Tarnacka
doaj   +1 more source

Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists

Journal of dermatology (Print), 2018
Although rheumatologists, neurologists and dermatologists see patients with polymyositis (PM) and dermatomyositis (DM), their management appears to vary depending on the physician's specialty.
H. Kohsaka, T. Mimori, T. Kanda, J. Shimizu, Y. Sunada, M. Fujimoto, Y. Kawaguchi, M. Jinnin, Y. Muro, S. Ishihara, H. Tomimitsu, Akiko Ohta, T. Sumida   +12 more
semanticscholar   +1 more source

Roles of macrophage migration inhibitory factor in polymyositis: Inflammation and regeneration

Journal of International Medical Research, 2018
Objective To elucidate the clinical significance of macrophage migration inhibitory factor (MIF) serum concentration in patients with polymyositis. Methods Thirty-six patients with polymyositis were enrolled.
Yu-Qiong Zou, Wei-Dong Jin, Ya-Song Li
doaj   +1 more source

Chronic-graft-versus-host-disease-related polymyositis: a 17-months-old child with a rare and late complication of haematopoietic stem cell transplantation.

Mediterranean Journal of Hematology and Infectious Diseases, 2020
Background: Chronic graft versus host disease (cGVHD) occurs in 20-30% of paediatric patients receiving haemopoietic stem cell transplantation (HSCT). Neuromuscular disorders such as polymyositis are considered a rare and distinctive but non-diagnostic ...
Matteo Chinello, Rita Balter, Massimiliano De Bortoli, Virginia Vitale, Ada Zaccaron, Elisa Bonetti, Paola Tonin, Gaetano Vattemi, Valeria Guglielmi, Simone Cesaro   +9 more
doaj   +1 more source